Background: Activity-regulated cytoskeleton-associated protein (Arc) transcription is activated by BDNF. Results: BDNF activated the Arc proximal promoter, whereas class I histone deacetylases (HDACs) inhibited this activation. Conclusion: Class I HDACs repress BDNF-induced Arc transcription through its serum response element-containing proximal promoter. Significance: Neuronal Arc expression is regulated by chromatin structure, which may lead to long-lasting changes in neuronal functions.
in accordance with the actions of BDNF (9, 16 -18) . A previous study in rats reported two waves of Arc induction in the hippocampus after a single spatial exploration, the second one of which spanned the interval from 8 to 24 h post-exploration (19) , and may involve the actions of BDNF in local translation at spines (9) . However, it currently remains unclear how Arc expression is regulated by neuronal activity or BDNF in terms of synaptic plasticity.
In this present study, we focused on transcriptional regulation of Arc in response to BDNF in cultured rat cortical cells and found that the proximal region of the Arc promoter controlled transcription in response to BDNF or FGF2, but that neuronal activity did not affect transcription to the same extent. We also assigned the regions responsible for the basal and BDNF-induced activation of Arc transcription in the proximal Arc promoter, the locations of which differed from those reported by Pintchovski et al. (5) . Through these regions, Arc transcription was controlled by class I histone deacetylase (HDAC). The repressive states of these regions regulated the responsiveness of Arc transcription to BDNF or FGF2. The results of the present study demonstrate novel regulation of Arc expression mediated by receptor tyrosine kinase (RTK) signaling in neurons. This regulation is related to the repressive activity of chromatin, and may provide a better understanding of the role of Arc expression in long-lasting changes of neuronal functions such as memory consolidation.
EXPERIMENTAL PROCEDURES
Reagents-K252a, U0126, NMDA, DL-2-amino-5-phosphopentanoic acid (DL-APV), trichostatin A (TSA), SAHA, and MC1568 were purchased from Sigma-Aldrich, MS-275 was from Focus Biomolecules (Plymouth Meeting, PA), FGF2 was from Miltenyi Biotec (Bergisch Gladbach, Germany). BDNF was generously donated by Dainippon Sumitomo Pharma Co., Ltd. (Osaka, Japan).
Cell Culture-Primary cultures of rat cortical neuronal cells were prepared from the cerebral cortices of 17-day-old Sprague-Dawley rat embryos (Japan SLC, Shizuoka, Japan) as previously described (20) . Animal care and all experiments were carried out in accordance with the Guidelines for the Care and Use of Laboratory Animals of the University of Toyama. Dissociated cells were suspended in DMEM (Invitrogen, Carlsbad, CA) containing 10% FCS, and 100 g/ml kanamycin (Invitrogen) and were seeded at 1.8 ϫ 10 6 cells in 35-mm culture dishes (for quantitative RT-PCR analysis and promoter analysis) (Asahi Techno Glass, Tokyo, Japan) or 5 ϫ 10 6 cells in 60-mm culture dishes (for chromatin immunoprecipitation (ChIP) assay) (Asahi Techno Glass). Culture dishes were coated with poly-L-lysine (Sigma-Aldrich). Cells were grown for 2 days and the medium was then replaced with transferrin-insulinsodium selenite (TIS) medium (serum-free DMEM containing 4.5 mg/ml glucose, 5 g/ml transferrin, 5 g/ml insulin, 5 ng/ml sodium selenite, 1 mg/ml BSA, 100 g/ml kanamycin sulfate), and 0.2 M cytosine arabinoside (Ara-C, Sigma-Aldrich). The medium was replaced 1 day later with Ara-C-free TIS medium.
Quantitative RT-PCR-RNA was isolated from cultured cells using a previously described protocol (20, 21) . Briefly, total RNA was isolated using TRIsure (BIOLINE, London, UK). One microgram of RNA was reverse-transcribed into cDNA using SuperScript II reverse transcriptase (Invitrogen), as previously described (20, 21) . Quantitative PCR amplification was performed using the Stratagene Mx3000p Real-Time PCR system (Agilent Technologies, Inc., Santa Clara, CA), as previously described (20, 21) . Standard curves were generated for each gene using a plasmid dilution series containing the target sequences. The threshold cycle for each sample was taken from the linear range and converted to the starting amount by interpolation from a standard curve. The levels of Arc and Bdnf exon I-IX mRNAs were normalized to that of glyceraldehyde-3-phosphate dehydrogenase (Gapdh). The primer sequences were as follows: Gapdh; 5Ј-ATCGTGGAAGGGCTCATGAC-3Ј and 5Ј-TAGC-CCAGGATGCCCTTTAGT-3Ј, Arc; 5Ј-CGCTGGAAGAAG-TCCATCAA-3Ј and 5Ј-GGGCTAACAGTGTAGTCGTA-3Ј, Bdnf exon I-IX; 5Ј-GACACATTACCTTCCAGCATC-3Ј and 5Ј-GCCCATTCACGCTCTCCA-3Ј.
Plasmids-We used the reporter plasmid, pGL4.12-Luc2CP (Promega) to measure Arc promoter activity. pGL4.12-rat Arc promoter/Ϫ1679 (pGL4.12-Arc/Ϫ1679) was generated by inserting the rat Arc promoter fragment Ϫ1679 bp to ϩ95 bp, amplified by PCR with the specific primers: 5Ј-ATGGTACCC-TGCCTTCTGTGTCCGCCTACT-3Ј and 5Ј-ATGAGCTCT-GCCGGAGGAGCTTAGCGAGTGT-3Ј, into the KpnI/SacI sites of pGL4.12-Luc2CP. The 5Ј-deleted mutant promoters, pGL4.12-Arc/Ϫ1374, Arc/Ϫ1139, Arc/Ϫ1107, Arc/Ϫ1067, Arc/Ϫ987, Arc/Ϫ940, Arc/Ϫ787, Arc/Ϫ659, Arc/Ϫ249, Arc/ Ϫ169, Arc/Ϫ93, Arc/Ϫ65, and Arc/Ϫ37 were generated by inserting the corresponding regions into the KpnI/SacI sites of the vector. pGL4.12-Arc/Ϫ1030 and Arc/Ϫ203 were generated by inserting the regions into the BglII/SacI sites of the vector. These regions were amplified by PCR with the common reverse primer: 5Ј-ATGAGCTCTGCCGGAGGAGCTTAGCGAG-TGT-3Ј and 5Ј-specific forward primers: Arc/Ϫ1374: 5Ј-TAATG-GTACCGTGAGTGGAGGCATGAGTCTACAGAG-3Ј, Arc/ Ϫ1249: 5Ј-TAATGGTACCAGGGGGAGTTGACAAAGAGG-GAAAGG-3Ј, Arc/Ϫ1139: 5Ј-TAATGGTACCGGAAGACCTA-GACCCATGTATCTGGC-3Ј, Arc/Ϫ1107: 5Ј-TAATGGTACC-TAAGCCAAGAAAGATGCCCTCC-3Ј, Arc/Ϫ1067: 5Ј-TAAT-GGTACCTGTTGCCAGGGAATCGGAAG-3Ј, Arc/Ϫ1030: 5Ј-ATAGATCTGAATCTCAGCTTCCGGAGCCCCATT-3Ј Arc/ Ϫ987: 5Ј-TAATGGTACCTTTCCTCTGCTGGCTCCTTCC-3Ј, Arc/Ϫ940: 5Ј-TAATGGTACCGTCCTCCAGTCTAACCT-CTTAGAAGTCTTG-3Ј, Arc/Ϫ787: 5Ј-ATGGTACCCAGGGC-ACTGCAGGCTACTGAC-3Ј, Arc/Ϫ659: 5Ј-ATGGTACCGAC-TTATGACTCTTGGGGCAATGATG-3Ј, Arc/Ϫ249: 5Ј-ATG-GTACCAAGATCCCTCCGGGTGGGAGGC-3Ј, Arc/Ϫ203: 5Ј-ATAGATCTCCGGGCTGTGAAGGGGCG-3Ј; Arc/Ϫ169: 5Ј-TAATGGTACCCGCGGAAGGGGAGCGAGTAG-3Ј, Arc/Ϫ93: 5Ј-TAATGGTACCGCCTGGGCGCGGCCAATG-3Ј, Arc/Ϫ65: 5Ј-TAATGGTACCCTCCGCGAGCTGCCGCC-3Ј, and Arc/ Ϫ37: 5Ј-TAATGGTACCCGCAGCATAAAAAGCCGCC-GGTG-3Ј.
Internally deleted promoters were generated using the KOD-Plus-Mutagenesis Kit (Toyobo, Osaka, Japan), according to the manufacturer's instructions. The primer sequences used were as follows; Arc/⌬Ϫ1100ϳϪ1083: 5Ј-ACTGCACCACAGCG-CTGTTGCCA-3Ј and 5Ј-TGGCTTACACCAAGCCAGATA-CAT-3Ј, Arc/⌬Ϫ1082ϳϪ1067: 5Ј-GTTGCCAGGGAATCG-GAAGG-3Ј and 5Ј-GGGGGAGGGCATCTTTCTTGGCTT-3Ј, Arc/⌬Ϫ1069ϳϪ1041: 5Ј-CCTCTAGAGGGAATCTC-AGC-3Ј and 5Ј-GCTGTGGTGCAGTGGGGGAGGGCAT-3Ј, Arc/⌬Ϫ1040ϳϪ1025: 5Ј-CAGCTTCCGGAGCCCCATTCC-TTA-3Ј and 5Ј-GAGGCCCCTTCCGATTCCCTG-3Ј, Arc/ ⌬Ϫ1027ϳϪ1009: 5Ј-ATTCCTTATATGGCATCTTGCT-TTC-3Ј and 5Ј-TTCCCTCTAGAGGGAGGCCCCTTC-CGA-3Ј and Arc/⌬Ϫ1008ϳϪ1000: 5Ј-ATGGCATCTTGCTT-TCCTCT-3Ј and 5Ј-GGGGCTCCGGAAGCTGAGA-3Ј. pGL4.11-Arc/Ϫ7000 bp and Arc/SARE were generously provided by Dr. H. Bito (Graduate School of Medicine, The University of Tokyo, Tokyo, Japan).
DNA Transfection and Measurement of Luciferase Activity-DNA transfection of cells was carried out at 3 days in vitro (DIV) using calcium phosphate/DNA precipitation as previously described (20) . Briefly, calcium phosphate/DNA precipitates were prepared with one volume (67 l) of plasmid DNA (6 g, F-luc:R-luc ϭ 10:1). In the experiment using ZnEGR1, ZnEGR3, and SP4 shRNA (shSP4), 2 g of the reporter plasmid (F-luc:R-luc ϭ 10:1) and 4 g of the expression vector (Empty vector, ZnEGR1, ZnEGR3, pSuper, or shSP4) were co-transfected. The knockdown of SP4 was performed as previously described (22) . The ZnEGR1 and ZnEGR3 expression vectors were generously provided by Dr. J. M. Baraban (The Johns Hopkins University). Plasmid DNA was dissolved in a 250 mM CaCl 2 solution with an equal volume of 2 ϫ HEPES-buffered saline, and added to cells in a 35-mm dish. After 30 min, the dish was washed two times with phosphate-buffered saline (PBS) and replenished with fresh TIS medium. After 40 h, transfected cells were treated with BDNF or vehicle for 6 h, and the lysate was extracted with 1ϫ passive lysis buffer (Promega). In the experiment using shSP4, neurons were treated with BDNF 72 h after DNA transfection. Dual (firefly and Renilla) luciferase activity was measured using the Dual-luciferase Reporter Assay System (Promega) with the TD-20/20 Luminometer (Promega).
ChIP Assay-ChIP assays were performed using the Magna ChIP A Kit (Millipore, Billerica, MA), according to the manufacturer's instructions. Approximately 1 ϫ 10 7 cells were used for each ChIP assay. Briefly, cells were cross-linked with 1% formaldehyde in culture medium for 10 min at room temperature. Cells were pelleted by centrifugation and then resuspended in cell lysis buffer. After cell lysis, lysates were centrifuged to pellet nuclei, and these were then resuspended in nuclear lysis buffer for sonication. These lysates were sonicated to share crosslinked DNA. After centrifugation, the supernatant (ϳ1 ϫ 10 6 cell equivalents of lysate) was diluted, and mixed with protein A magnetic beads and a specific antibody (10 g of anti-EGR1 (558X, Santa Cruz Biotechnology, Dallas, TX), 10 g of anti-SP4 (v-20X, Santa Cruz Biotechnology), 10 g of anti-SRF (G-20X, Santa Cruz Biotechnology), or 3 l of anti-HDAC1 (17-10199, Millipore)) overnight at 4°C with rotation. The precipitated protein/DNA complex was washed and eluted in elution buffer with proteinase K. The eluted DNA was purified by a spin filter. The purified DNA was amplified using KOD FX DNA polymerase (Toyobo). The primer sequences used were as follows: Region-1; 5Ј-CAGTGATATGTCCCCAAGTAAC-ATC-3Ј and 5Ј-CCAGAAGCTTCAAGACTTCTAAGAG-3Ј, Region-2; 5Ј-GTCACTCCGGGCTGTGAA-3Ј and 5Ј-GGCG-GCTTTTTATGCTGCG-3Ј. PCR products were separated on 2% agarose gels. The amplification of Region-2 was also performed using the Stratagene Mx3000p Real-Time PCR system (Agilent Technologies) with a SYBR Select Master Mix (Invitrogen).
Statistics-All values represent the mean Ϯ S.E. for the number of separate experiments performed in duplicate, as indicated in the corresponding figures. Statistical analyses were performed using a one-way ANOVA with Sheffe's F test. Student's t test followed by the F test was also used (Figs. 1, D-F, 4A, and 8B).
RESULTS
Proximal Region of the Arc Promoter Was Activated by BDNF or FGF2, but Not by NMDA Receptor Activation-We investigated changes in the expression of Arc mRNA following treatment of primary cultures of rat cortical cells with BDNF. As shown in Fig. 1A , Arc expression was markedly induced 1 h after BDNF treatment, and the induction was abolished by the addition of K252a or U0126, inhibitors of tropomyosin-related kinase (Trk) signaling and MEK1/2, respectively ( Fig. 1A) .
These results indicated that the TrkB-Ras-ERK/MAPK pathway was involved in BDNF-induced Arc expression.
We then constructed a reporter plasmid to clarify the transcriptional regulation of Arc. We focused on the proximal region of the Arc promoter, the activation of which can be controlled by Ca 2ϩ and cAMP signals (3). The rat Arc promoter region from Ϫ1679 to ϩ95 bp ( Fig. 2 ) was fused to the firefly luciferase gene (Arc/Ϫ1679). Corresponding to the induction of Arc expression ( Fig. 1A) , BDNF significantly activated Arc/ Ϫ1679 transcription, which was abolished in the presence of K252a or U0126 ( Fig. 1B) .
Previous studies have established that the expression of Arc is activated by neuronal activity (1, 2, 4, 5) . Consistent with this finding, we found that the expression of Arc mRNA was also increased by the direct activation of NMDA receptor (NMDAR) with exogenously added NMDA (Fig. 1C ). However, Arc mRNA expression was also increased by the treatment of cortical cells with FGF2 ( Fig. 1C ). NMDA-induced Arc expression was suppressed by APV, while that induced by FGF2 was suppressed by U0126 (Fig. 1C ). The promoter activity of Arc/ Ϫ1679 was activated by FGF2, but not by NMDA ( Fig. 1D ).
Because the distal enhancer, SARE, has been shown to play a crucial role in Arc induction (4), we measured Arc promoter activity using the Arc promoter encompassing Ϫ7 kbp upstream of the transcriptional start site (Arc/Ϫ7000) (4). Arc/ Ϫ7000 was markedly activated by BDNF, and also by NMDA or FGF2 (Fig. 1E) , and corresponded to the changes in the mRNA levels ( Fig. 1, A and C) . To investigate the role of the SARE in Arc promoter activation, we used the reporter plasmid in which the SARE fragment was fused to the minimum region of the CMV promoter (Arc/SARE) (4) . Arc/SARE was also activated by BDNF, NMDA, or FGF2 ( Fig. 1F) , although the induction level of Arc/SARE was slightly lower than that with Arc/Ϫ7000 (Fig. 1E ). These results indicated that RTK signaling, which is activated by neurotrophic or growth factors such as BDNF and FGF2, respectively, induced the expression of Arc via the distal SARE enhancer and the proximal region of the Arc promoter, whereas NMDAR activation-induced Arc expression was mainly mediated by SARE.
Identification of BDNF-responsive Elements in the Proximal Region of the Arc Promoter-The binding sites of transcription factors, such as SRF, activator protein 1 (AP1), EGR, and specificity protein (SP) family transcription factors, have been identified in Arc/Ϫ1679 (Fig. 2) (3, 5, 6, 15). To identify the region involved in BDNF-induced Arc/Ϫ1679 activation, we constructed a series of deletion mutants of the proximal promoter ( Fig. 3A ). As shown in Fig. 3B , compared with Arc/Ϫ1679, the increases in basal promoter activity (promoter activity in the absence of BDNF) were significant in Arc/Ϫ1030, Arc/Ϫ987, Arc/Ϫ940, Arc/Ϫ787, Arc/Ϫ659, Arc/Ϫ249, Arc/Ϫ203, and Arc/Ϫ169. Significant decreases in basal activity were detected in Arc/Ϫ65 and Arc/Ϫ37 (Fig. 3B ). In particular, the deletion of the regions encompassing Ϫ1067 to Ϫ987 bp and Ϫ940 to Ϫ659 significantly increased the basal activity ( Fig. 3B ), suggesting that these regions negatively regulate the Arc proximal promoter. Although the basal level of Arc/Ϫ93 was the same as that of Arc/Ϫ1679, the basal activity of Arc/Ϫ93 was significantly reduced, compared with that of Arc/Ϫ169 (Fig. 3B ). Furthermore, the deletion of the region encompassing Ϫ93 to Ϫ37 significantly reduced the basal activity ( Fig. 3B ). This suggests that the region encompassing Ϫ169 to Ϫ37 positively regulated the Arc proximal promoter. In contrast, compared with Arc/ Ϫ1679, significant reductions of BDNF-induced promoter activation (fold-induction) were observed for Arc/Ϫ1030, Arc/ Ϫ987, Arc/Ϫ940, Arc/Ϫ787, Arc/Ϫ659, Arc/Ϫ249, Arc/Ϫ203, Arc/Ϫ169, Arc/Ϫ93, Arc/Ϫ65, and Arc/Ϫ37 (Fig. 3C ). Notably, promoter activation was significantly reduced when the regions encompassing Ϫ1107 to Ϫ1067 bp and Ϫ1067 to Ϫ940 bp were deleted ( Fig. 3C ), suggesting that these regions participate in the BDNF-induced activation of the Arc proximal promoter. The promoter activity of Arc/Ϫ1249 was not significantly different to that of Arc/Ϫ1374, despite two Zeste-like elements, which have been shown to be involved in BDNF-induced Arc promoter activation (5) , being deleted in Arc/Ϫ1249. Compared with the BDNF-induced activation of Arc/Ϫ940, that of Arc/Ϫ37, but not that of Arc/Ϫ65, was significantly decreased ( Fig. 3C ), suggesting that the region encompassing Ϫ65 to Ϫ37 bp is involved in BDNF-induced activation. Based on these statistical analyses (Fig. 3, B and C), we termed the region encompassing Ϫ1107 to Ϫ940 bp "Region-1" (Fig. 3 ), which could negatively regulate the basal promoter activity but positively regulate BDNF-induced activation (Fig. 3 , B and C). We also termed the region encompassing Ϫ169 to Ϫ37 bp "Region-2" (Fig. 3 ), which could positively regulate both the basal activity and BDNF-induced activation of the promoter (Fig. 3, B and C) . Although the region encompassing Ϫ940 to Ϫ659 bp negatively regulated the Arc proximal promoter ( Fig. 3B ), we focused on Region-1 and Region-2, which could be involved in the basal transcriptional activity and BDNF-induced activation of the Arc/Ϫ1679. Involvement of Zinc-finger Transcription Factors, EGR1 and SP4, in the Regulation of the Arc Proximal Promoter-Region-2 is a GC-rich region and contains binding sites for transcription factors such as SP and EGR family members (Fig. 2) . We previously reported that, among SP family transcription factors, SP3 and SP4 were expressed in the nuclei of cultured rat cortical cells (22) . We also found that mRNA levels of Egr1, Egr2, and Egr4, but not that of Egr3, were strongly up-regulated by BDNF (23) . Moreover, among the EGR family transcription factors, EGR1 and EGR3 were previously shown to be able to bind the EGR-response element (ERE) located in Region-2 (15) . Therefore, we focused on SP3/4 and EGR1 in the present study. Although the expression of a dominant negative SP3 did not affect Arc/Ϫ1679 activity (data not shown), the knockdown of SP4 reduced the basal activity of Arc/Ϫ1679, but not BDNFinduced activation of the promoter (Fig. 4A) . We have already demonstrated that levels of endogenous SP4 protein are decreased in the neurons transfected with shSP4, but not with control vector (22) . However, the BDNF-induced activation of Arc/Ϫ1679 was partially prevented by the co-expression of a dominant negative EGR, ZnEGR1, or ZnEGR3 (Fig. 4B ). These dominant negative EGRs also slightly reduced the basal activity of the promoter (Fig. 4B) . The effects of dominant negative EGR and SP4 knockdown on Arc/Ϫ1679 were similar to those on Arc/Ϫ169 (data not shown), indicating that SP4 and EGR controlled the basal activity and BDNF-induced activation of Arc/ Ϫ1679 via Region-2. Using the chromatin immunoprecipitation (ChIP) assay, we detected the binding of SP4 and EGR1 to Region-2. In addition, the binding to this region increased slightly with BDNF treatment, especially for EGR1 ( Fig. 4C) .
Identification of BDNF-responsive Elements in Region-1 of the Arc Proximal Promoter-By focusing on Region-1, we further examined the regions involved in the regulation of the Arc proximal promoter using the internal deleted mutants of Arc/Ϫ1139 (Fig. 5A ). Compared with Arc/Ϫ1139, significant increases in basal promoter activity were detected for Arc/⌬Ϫ1040ϳϪ1025, Arc/ ⌬Ϫ1027ϳϪ1009, and Arc/⌬Ϫ1008ϳϪ1000, while a reduction was observed for Arc/⌬Ϫ1100ϳϪ1083 (Fig. 5B) . Also, significant reductions of BDNF-induced activation of the promoter were observed for Arc/⌬Ϫ1082ϳϪ1067, Arc/⌬Ϫ1069ϳϪ1041, Arc/⌬Ϫ1040ϳ Ϫ1025, Arc/⌬Ϫ1027ϳϪ1009, and Arc/⌬Ϫ1008ϳϪ1000 (Fig.  5C ). Deletion of the region encompassing Ϫ1008 to Ϫ1000 bp produced both an increase in basal activity and a decrease in BDNF-induced promoter activation (Fig. 5, B and C) . This MARCH 13, 2015 • VOLUME 290 • NUMBER 11
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region contains a cis-regulatory element, the binding site of SRF (Fig. 2) . Moreover, the region encompassing Ϫ1027 to Ϫ1009 bp, which also affected the activity of the promoter (Fig. 5, B and C), contains the binding site of the E-twenty six (Ets) transcription factor family, a cofactor of SRF (Fig. 2) . Therefore, these regions, which contain cis-regulatory elements involved in SRF-dependent transcription, could negatively regulate basal promoter activity, but could also be involved in the BDNFinduced activation of the Arc proximal promoter.
HDAC Inhibition Enhanced BDNF-induced Arc Expression-Analysis of a series of deleted mutants revealed that Region-1 negatively regulated Arc expression; therefore, we hypothesized that some negative transcriptional factors could be involved in the repression of Arc expression. As SRF and Etslike transcription factor 1 (Elk1), binding sites for which are present in Region-1, were previously reported to interact with HDACs (24, 25) , it is possible that Arc transcription is suppressed by HDAC-mediated repressive machinery. Therefore, we examined the effects of trichostatin A (TSA), an inhibitor of HDAC, on Arc expression. Although Arc mRNA levels were slightly increased 12 h after treatment with TSA only, this increase was not observed at other time points (3, 6, and 24 h) ( Fig. 6A ). Valproic acid (VPA), another inhibitor of HDAC, also did not affect Arc expression (21) . In contrast, levels of Bdnf exon I-IX mRNA, the expression of which was previously shown to be repressed by the RE-1 silencing transcription factor (REST)/HDAC-mediated mechanism (26, 27) , markedly increased after TSA treatment in a time-dependent manner ( Fig. 6B ), suggesting that TSA effectively inhibited HDAC in this culture system. In contrast to the non-responsiveness of basal Arc expression to TSA, the up-regulation of Arc mRNA levels by BDNF was markedly enhanced in the presence of TSA in a dose-dependent manner (Fig. 6C) . The enhancing effect of TSA on BDNF-induced Arc mRNA levels was also detected when cells were treated with FGF2 ( Fig. 6D) . In contrast, TSA did not enhance, but inhibited NMDA-induced Arc mRNA levels ( Fig. 6D) . Thus, TSA selectively enhanced RTK signalinginduced Arc expression. This enhancing effect of TSA likely corresponded with regulation of transcription from the proximal promoter, which can be activated by BDNF or FGF2, but not by NMDA ( Fig. 1) .
TSA is a pan-HDAC inhibitor. We next examined the effects of other HDAC inhibitors. We used SAHA, a class I/IIb HDAC inhibitor (28), MS-275, a selective class I HDAC inhibitor (29, 30) , and MC1568, a selective class II HDAC inhibitor (31, 32) . As reported recently (33) , these HDAC inhibitors did not affect basal Arc mRNA levels (Fig. 6, E and F) . The BDNF-induced increase in Arc mRNA levels was robustly enhanced by SAHA and also significantly by MS-275 ( Fig. 6E) . MC1568 had no effect on BDNF-induced Arc mRNA levels (Fig. 6E) , indicating that a class I HDAC was, at least in part, involved in the repression of BDNF-induced Arc expression. However, NMDA-induced Arc mRNA expression was inhibited by SAHA, MS-275, or MC1568 (Fig. 6F) .
The Enhancing Effect of TSA on Arc Transcription Because of SRF and Elk-1 Binding Sites Located in Region-1 of the Proximal
Promoter-As shown in Fig. 7A , we showed that the BDNFinduced transcriptional activation of Arc/Ϫ1679 was synergistically enhanced by TSA, indicating that the enhancing effect of TSA occurred at the transcriptional level. Using a series of deletion mutants (Figs. 3 and 5 ), we found that the enhancing effect of TSA was also observed in Arc/Ϫ1139 and Arc/Ϫ1107, but that the effect of TSA was significantly reduced in Arc/Ϫ987 and Arc/Ϫ203 (Fig. 7A) . Further analyses showed that the enhancing effect of TSA was significantly attenuated when the region encompassing Ϫ1027 to Ϫ1009 bp or Ϫ1008 to Ϫ1000 bp, which includes the cis-regulatory elements involved in the control of SRF-mediated transcription, was deleted ( Fig. 7B) .
We performed ChIP assays with a specific antibody for HDAC1 or SRF to determine whether HDAC1 and SRF bound to Region-1. As shown in Fig. 8 , we detected the binding of HDAC1 and SRF to Region-1. Using quantitative PCR analysis, we found that, although SRF binding did not change 24 h after TSA treatment, HDAC1 binding significantly decreased under the same condition (Fig. 8) . Thus, Region-1 negatively regulated Arc expression and the release of HDAC1 from Region-1 could, at least in part, allow the expression of Arc to be strongly induced in response to BDNF. treated with TSA for 24 h, and BDNF was then added to the TSA-treated or non-treated cells. One hour after BDNF treatment, total RNA was extracted, and the levels of Arc mRNA were measured by quantitative RT-PCR analysis. Values represent the mean Ϯ S.E. (n ϭ 3-4). *, p Ͻ 0.05 and **, p Ͻ 0.01 versus control (the sample without TSA/BDNF). D, twenty-four hours after the 800 nM TSA treatment, cells were further treated with NMDA or FGF2 for 1 h. Values represent the mean Ϯ S.E. (n ϭ 3-4). **, p Ͻ 0.01 versus control (the sample without NMDA or FGF2). † †, p Ͻ 0.01 versus vehicle (the same sample without TSA). E and F, effects of SAHA, MS-275, and MC1568 on BDNF (E) or NMDA (F)-induced Arc expression. Twenty-four hours after the HDAC inhibitor treatment, cells were further treated with BDNF or NMDA for 1 h. The concentration for each HDAC inhibitor (5 M) was taken from a previous report (33) . Values represent the mean Ϯ S.E. (n ϭ 3-4). **, p Ͻ 0.01 versus control (the sample without BDNF). † †, p Ͻ 0.01 versus vehicle (the same sample without HDAC inhibitors). NS: not significant.
DISCUSSION
By focusing on BDNF-induced Arc transcription using Arc/ Ϫ1679, we herein demonstrated that the proximal region of the Arc promoter contributed to the transcriptional regulation of Arc (Fig. 9 ), although the distal enhancer, SARE, has previously been shown to play a crucial role in activity-dependent Arc expression (4). Arc/Ϫ7000 and Arc/SARE were activated by NMDAR activation, whereas Arc/Ϫ1679 was activated by BDNF or FGF2, but not by NMDA. These results indicate that the SARE could mediate NMDAR-induced Arc expression, which is consistent with previous findings (4), while not only SARE but also the proximal promoter are involved in BDNF-or FGF2-induced Arc expression. Because both of the receptors for BDNF and FGF2 are RTK members, RTK signaling and NMDAR activation differentially control Arc expression via two distinct promoter regions, the SARE and the proximal promoter.
Using a series of deletion mutants of the Arc promoter, we identified two regulatory regions, termed Region-1 and Region-2, in Arc/Ϫ1679 (Fig. 9 ). In the present study, we demonstrated that EGR1 and SP4 bound to GC-rich Region-2 to regulate the basal activity and BDNF-induced activation of the Arc promoter, respectively. EGR1 is an activity-dependent IEG and contributes to the expression of long-lasting changes in neuronal functions such as long-term memory (34) . Peng et al. (6) previously reported the involvement of EGR1 in PDGF-induced Arc expression. Thus, EGR1 appears to be important for RTK signaling-induced Arc expression. However, ZnEGRs, which is a highly conserved DNA-binding domain of all four EGR family transcription factors, partially inhibited BDNF-in- duced activation of Arc/Ϫ1679, whereas dominant negative EGRs almost completely suppressed nerve growth factor (NGF)-induced EGR-dependent transcription (35) . In addition, knockdown of endogenous SP4 significantly reduced the basal activity of Arc/Ϫ1679, but not the BDNF-induced activation. Therefore, other factors are also likely be involved in the BDNFinduced activation of Arc/Ϫ1679. Among the SP family transcription factors, SP4 is predominantly expressed in neuronal cells (36) and contributes to the transcriptional regulation of neuronal genes, such as neurotrophin-3 (Nt-3) (22) . Previous studies also reported that SP4 was involved in neuronal functions such as dendritic patterning in the cerebellum (37) , development of the hippocampal dentate gyrus (38) , and sensorimotor gating and memory (39) . Therefore, the SP4-mediated transcriptional regulation of Arc may be involved in the regulation of several types of physiological functions in the brain.
Pintchovski et al. (5) reported that the binding site of the invertebrate transcription factor, Zeste, was involved in Arc promoter activation. However, using 5Ј-deleted promoters, we could not confirm whether deletion of the region including Zeste-like elements altered activation of the proximal promoter. Therefore, it is unlikely that Zeste-like elements participated in activation of the Arc promoter. Pintchovski et al. (5) examined the enhancer activity of the region including Zestelike binding sites fused to the simian virus 40 (SV40) promoter, but not to the natural Arc promoter, which may be the reason why their results are different from ours.
The results obtained in the present study with internal deletion mutants of the Arc proximal promoter indicated that Region-1, including the cis-regulatory elements responsible for SRF-dependent transcription, negatively controlled basal promoter activity and positively controlled BDNF-induced promoter activation. We focused on the negative regulation of Arc expression via Region-1, and examined the effects of TSA on Arc expression. The levels of Arc mRNA did not change in neurons treated with TSA. However, the levels of Bdnf exon I-IX mRNA significantly increased in a time-dependent manner upon the TSA treatment because the Bdnf promoter I is remotely repressed by the RE-1 sequence located ϳ1 kbp downstream of promoter I through HDAC-mediated repressive activity (27) . These findings indicate that the repressive state of the Arc promoter differed from that of Bdnf promoter I, and that HDAC inhibition, which has been shown to accelerate the acetylation of histones, leading to the activation of gene transcription (40) , was not sufficient for Arc induction. However, it is important to note that BDNF-induced Arc expression was markedly enhanced in the presence of TSA, and that this was not observed for Bdnf exon I-IX (data not shown). This result suggested that the repressive state of the chromatin structure could be erased by TSA and that the transcriptional machineries activated by BDNF could be easily recruited to the proximal region of the Arc promoter, resulting in the marked induction of Arc expression by BDNF. This enhancing effect of TSA was also observed in FGF2-induced, but not NMDA-induced, Arc expression, indicating that RTK signaling-induced Arc expression could be regulated by common mechanisms including chromatin structure dynamics. We also demonstrated that a selective class I HDAC inhibitor, but not a class II inhibitor, significantly enhanced BDNF-induced Arc expression. Because HDAC1 bound to the region around Region-1, HDAC1 could, at least in part, be involved in the repression of BDNF-induced Arc expression. Although SAHA inhibits class I/IIb HDACs, MS-275 preferentially inhibits HDAC1, 2, and 3 (30) . This different range of inhibition may be one reason why the enhancing effect of SAHA on the Arc induction was stronger than that of MS-275. However, all HDAC inhibitors used in this study significantly suppressed NMDA-induced Arc expression, suggesting that most HDACs are likely to be involved in the induction by NMDA. In this study, however, it remains unresolved as to how HDACs positively control NMDA-induced Arc expression. Although HDAC inhibition could be artificially achieved by TSA in cultured neurons, it currently remains unclear how repressive activity mediated by HDAC could be released under the physiological conditions present in the brain. In the case of c-fos, HDAC1 is known to be recruited to the promoter region via the transcriptional co-repressor retinoblastoma protein (Rb), chromatin remodeling factor BRG1, and Ca 2ϩ -responsive transactivator (CREST), in the absence of neuronal activity (41) , whereas HDAC1 dissociates from the Rb/BRG1/CREST complex when neurons are stimulated in an activity-dependent manner. Furthermore, a previous study reported that HDAC1 could interact with Elk1 (24) , which is a coactivator of SRF and binds to the Ets transcription factor family-binding site. Because the effects of TSA were attenuated by deletion of the binding sites for SRF and Ets transcription factor located in Region-1, it is plausible that the binding of HDAC1 to Region-1 could be reduced in an activity-dependent manner, resulting in an enhancement in BDNF-induced Arc expression. Further investigations are needed to clarify this possibility.
Evidence has accumulated to show that the combination of both BDNF and Arc actions plays an important role in the expression of various neuronal functions (9, 42) . Messaoudi et al. (11) reported that Arc protein synthesis was required for BDNF-induced LTP. Furthermore, two waves of Arc induction have been observed after a single spatial exploration (19) . We previously demonstrated that the robust stimulation of TrkB with BDNF in cultured rat cortical cells induced the biphasic expression of Bdnf mRNA, which was observed 1-3 h (primary induction) and 24 -72 h (secondary induction) after the stimulation, and that this biphasic expression of Bdnf mRNA was accompanied by a similar expression profile for Arc mRNA (43) . It is important to note that the induction of Arc mRNA in the secondary phase was mediated by the binding of endogenously synthesized BDNF to TrkB, while the secondary induction of Bdnf mRNA was controlled in an activity-dependent manner (43) . Therefore, the distinct usage of the SARE and the proximal Arc promoter may be involved in the control of two waves of Arc induction (19) ; the secondary wave of Arc synthesis could be mainly mediated by the interaction between secreted BDNF and TrkB under cellular conditions in which HDAC1-mediated repressive activity may have been released from the Arc promoter. Thus, BDNF-induced Arc expression could provide a clearer understanding of the molecular mechanisms underlying Arc-mediated long-lasting changes in neuronal functions in the brain.
